Understanding how a specific protein affects immune response in certain cancers caused by papillomavirus
Investigating the mechanism of K17-mediated immunosuppression in papillomavirus-induced cancers
This study is looking at how a protein called keratin 17 helps HPV-related cancers hide from the immune system, with the goal of finding new ways to improve treatments for patients battling these types of cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Henry Ford Health + Michigan State University Health Sciences NIH-funded |
| Lab location | 1 site (East Lansing, United States) |
| Project ID | NIH-10885642 on NIH RePORTER |
What this research studies
This research investigates how the protein keratin 17 (K17) contributes to immune suppression in cancers associated with human papillomavirus (HPV). By using a mouse model of papillomavirus infection, the study aims to uncover the molecular mechanisms that allow K17 to help the virus persist and evade the immune system. The findings could lead to new therapeutic targets that enhance cancer immunotherapy treatments for patients with HPV-related cancers. The research focuses on understanding the tumor microenvironment and how it can be manipulated to improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with HPV-related cancers, such as anal or cervical cancer.
Not a fit: Patients with cancers not associated with HPV or those who do not have a significant immune response may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective immunotherapy options for patients with HPV-related cancers.
How similar studies have performed: Previous research has shown promising results in understanding immune suppression mechanisms in cancer, suggesting that this approach could yield valuable insights.
Where this research is happening
East Lansing, United States
- Henry Ford Health + Michigan State University Health Sciences — East Lansing, United States (Active)
Researchers
- Principal investigator: Wang, Wei — Henry Ford Health + Michigan State University Health Sciences
- Study coordinator: Wang, Wei
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.